Role of investigational monoclonal antibodies in the treatment of multiple myeloma: A systematic review.
Hamza Hassan(Roswell Park Comprehensive Cancer Center), Faiz Anwer(Cleveland Clinic), Abdul Rafae(University of Arkansas for Medical Sciences), Adeela Mushtaq(University of Pittsburgh Medical Center), Abraham S. Kanate(HonorHealth), Faryal Razzaq(University of Arizona), Jason Valent(Cleveland Clinic), Ahmad Iftikhar(University of Arizona), Nimra Iftikhar(Dow University of Health Sciences), Rajshekhar Chakraborty(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2020|278
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
|Blood|2015|273
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
|Blood|2017|247